| NDC Code: |
55714-4552 |
| Proprietary Name: |
Exhaustion Chronic Fatigue |
| Suffix: |
|
| Non-Proprietary Name: |
Aconitum nap., Adrenalinum, Aralia quinquefolia, Arnica, Arsenicum alb., Baptisia, Bryonia, Cantharis, Chelidonium majus, Cinchona, Iodium, Kali carb., Kali iod.,Lachesis,Lycopodium, Lycopus virginicus, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabal, Thyroidinum, Echinacea, Gingko, Phytolacca, alcohol |
| Dosage Form: |
LIQUID |
| Method: |
ORAL |
| Original Marketing Date: |
01-06-2011 |
| Category Name: |
UNAPPROVED HOMEOPATHIC |
| Application Number: |
|
| Labeler: |
NEWTON LABORATORIES, INC. |
| Substance Name: |
ACONITUM NAPELLUS; AMERICAN GINSENG; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; GINKGO; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM IODIDE; PULSATILLA VULGARIS; SAW PALMETTO; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF |
| Active Numerator Strength: |
20; 20; 20; 20; 20; 20; 20; 20; 3; 8; 20; 3; 8; 20; 20; 20; 20; 20; 20; 3; 8; 20; 20; 20; 20; 20; 20; 20; 20 |
| Active Ingredient Unit: |
[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
| Pharm Classes: |
Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |
| DEA Schedule: |
|
